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 1 
ABSTRACT 2 
Blood-borne markers of fatigue such as Creatine Kinase (CK) and Urea (U) are widely used 3 
to fine-tune training recommendations. However, predictive accuracy is low. A possible 4 
explanation for this dissatisfactory characteristic is the propensity of athletes to react with 5 
different patterns of fatigue indicators (e.g. predominantly muscular (CK) or metabolic (U)). 6 
The aim of the present trial was to explore this hypothesis by using repetitive fatigue-7 
recovery cycles. 22 elite junior swimmers and triathletes (18 ±3 years) were monitored for 8 
nine weeks throughout two training phases (low-intensity, high-volume (LIHV) and high-9 
intensity, low-volume (HILV)). Blood samples were collected each Monday (recovered) and 10 
Friday (fatigued) morning. From measured values of CK, U, free-testosterone (FT), and 11 
cortisol (C) as determined in the rested and fatigued state, respectively, Monday-to-Friday 12 
differences (∆) were calculated and classified by magnitude before calculation of ratios 13 
(∆CK/∆U and ∆FT/∆C). Coefficient of variation (CV) was calculated as group-based 14 
estimates of reproducibility. Linear mixed modelling was used to differentiate inter- and 15 
intra-individual variability. Consistency of patterns was analysed by comparison to threshold 16 
values (<0.9 or >1.1 for all weeks). Reproducibility was very low for fatigue-induced 17 
changes (CV ≥100%) with inter-individual variation accounting for 45-60% of overall 18 
variability. Case-wise analysis indicated consistent ∆CK/∆U patterns for seven individuals in 19 
LIHV and seven in HILV; five responded consistently throughout. For ∆FT/∆C the number 20 
of consistent patterns was two in LIHV and three in HILV. These findings highlight the 21 
potential value of an individualised and multivariate approach in the assessment of fatigue. 22 
 23 
 24 
KEYWORDS: Exercise, Regeneration, Reproducibility, Surrogate markers, Training25 
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 26 
INTRODUCTION: 27 
The decisive difference in performance separating the winner from a challenger is generally 28 
tiny in today’s competitive sports, in particular among elite athletes (1). As such, maximising 29 
training adaptation by fully utilising the limits of bearable training load is critical for success. 30 
However, such an approach is associated with the risk of accumulating fatigue, non-31 
functional overreaching and ultimately the overtraining syndrome (21). Therefore, 32 
monitoring of fatigue and recovery is an important aspect in the regular fine-tuning of 33 
training recommendations in competitive sports. 34 
 35 
A key feature of exercise-induced fatigue is a decline in discipline-specific performance 36 
capacity. However, repeated exhaustive performance tests are hard to integrate in the training 37 
regime and would contribute considerably to the overall fatigue burden of athletes. Therefore, 38 
various surrogate markers have been proposed including a wide range of blood-borne 39 
parameters (2, 16, 21, 25-26) as well as psychological (11) and autonomic (16, 24) measures 40 
(6, 21). Blood-borne parameters are particularly attractive surrogate markers of fatigue and 41 
recovery because of their obvious objectivity, their high accuracy and precision of 42 
measurements, the minimal interference with the training process, and, in most cases, a clear 43 
physiological concept concerning their connection with exercise and fatigue (18). 44 
 45 
Ideally, a surrogate measure of fatigue and recovery is characterised by high reliability of 46 
their values, at any given level of fatigue and large fatigue-induced changes. Surprisingly, so 47 
far no parameter could be established which has adequate sensitivity and reproducibility for 48 
the monitoring of fatigue and recovery during athletic training cycles (6, 11, 15). In 49 
particular, gross variability is high and little is known about the proportion of between and 50 
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within-subject differences (3). This problem concerns measured values as well as fatigue-51 
induced changes of virtually all blood-borne indicators presented in the literature thus far 52 
(16). The known mechanisms behind this variability include lifestyle dependent (e.g. 53 
nutrition (21), hydration, sleep (19) as well as subject inherent (e.g. age, sex, ethnicity (4)) 54 
and methodological factors (e.g. strict circadian and procedural standardization needed in 55 
particular for hormone and autonomic measures (16, 21, 24)).  56 
 57 
Another possible explanation for this unsatisfactory characteristic could be a variable pattern 58 
of fatigue-induced changes between athletes. If some athletes responded predominantly with 59 
changes in parameter A and others with changes in parameter B, a group-based analysis of 60 
fatigue-induced changes will inevitably show high variability for changes in either measure. 61 
This explanatory approach originated from observations of experienced team physicians from 62 
endurance disciplines with the routine parameters Creatine Kinase (CK) and Urea (U). CK is 63 
commonly used as marker of muscular strain and is particularly elevated with exercise modes 64 
including high levels of eccentric work and peak force (4, 16). By contrast U, the excretal 65 
form of nitrogen in the human body, reflects protein catabolism occurring with high calorie 66 
turnover and metabolic strain (16, 21). While the majority of athletes are reported to have 67 
variable relationships between the two parameters, some athletes consistently show a marked, 68 
fatigue-dependent increase in CK with marginal changes in U and for some other individuals 69 
from the same discipline the observed relationship was reversed. Similar observations have 70 
been made for changes in Free-testosterone (FT) and Cortisol (C). FT is the biologically 71 
active form of testosterone, the most potent anabolic hormone. FT strongly promotes a 72 
multitude of anabolic pathways essential for recovery after physical exercise. These include 73 
protein synthesis, nutrient uptake into muscle cells and glycogen resynthesis. C is a catabolic 74 
hormone mediating e.g. protein breakdown for gluconeogenesis and glycogenolysis during 75 
Copyright ª 2016 National Strength and Conditioning Association
AC
CE
PT
ED
  
Individual patterns in blood-borne indicators of fatigue 4 
prolonged exposures to stress. The ratio FT/C reflects the anabolic/catabolic balance and has 76 
been shown to be reduced during non-functional overreaching and the overtraining syndrome 77 
(16, 25, 26). 78 
 79 
Therefore, the three-fold purpose of this study was to determine a) the reproducibility of four 80 
routine (CK, U, FT and C) blood-borne parameters and their fatigue-induced changes, b) the 81 
proportion of between- and within-subject variability of the fatigued induced changes, and c) 82 
the main aim was to observe whether consistent individual patterns of fatigue-induced 83 
responses for different markers are existent.  84 
 85 
METHODS: 86 
Experimental approach to the problem 87 
The general design of this study represents an observational approach. Elite junior athletes 88 
were monitored for a total of nine weeks during two distinct training phases as described by 89 
the team coaches (low intensity, high volume (LIHV) and high intensity, low volume 90 
(HILV), respectively). According to the repetitive structure of the weekly microcycles, blood 91 
samples were collected before the first training of the day on Mondays (recovered after 92 
resting on Sunday) and Fridays (fatigued after a week of training).  93 
 94 
Subjects 95 
A total of twelve (eight male, four female) athletes completed the study. Only junior elite 96 
swimmers and triathletes from a federal Olympic Training Centre were eligible for this trial. 97 
Further inclusion criteria included all athletes being required to complete three or more weeks 98 
of training throughout a training period to be included in the analysis and to be free from any 99 
form of illness or injury. All participants gave a written consent to take part in the study; for 100 
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those under the age of consent, parental permission was obtained. The institutional review 101 
board in the spirit of the Helsinki declaration approved the study. The timeline of subjects 102 
throughout the study is displayed in figure 1. 103 
  104 
Figure 1 about here 105 
 106 
Procedures 107 
Four, well studied, routine parameters of fatigue and recovery were selected as outcome 108 
measures for the study (26). These parameters were chosen due to their potential to form 109 
logical and meaningful pairs (ratios) (26). These include, CK which represents the muscular 110 
and U which represents the metabolic aspects of fatigue (17), as well as, FT and C of which 111 
the ratio has been previously established as a marker of the anabolic / catabolic balance (25). 112 
 113 
Venous blood samples were obtained from the anti-cubital vein in a supine position by 114 
standard protocol, following 10-15 min of seated rest. Blood was collected during the 115 
morning hours prior to the first training session of the day. Samples representing the 116 
recovered state were collected on Mondays after a day of rest, whilst samples representing 117 
fatigued status were collected on Fridays, in the morning before training, following a week of 118 
continuous training (Monday to Thursday). Training was logged for every athlete by the 119 
responsible coaches and checked by the research team to verify repetitive microcycles 120 
(Figure 2). Athletes were asked to keep meals and eating patterns consistent throughout the 121 
measuring period, no standardised food intake protocol or food diaries were upheld. 122 
 123 
Figure 2 about here 124 
 125 
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Blood samples were transported immediately to the laboratory for appropriate procedures. 126 
Serum tubes were centrifuged at 2,500 revolutions per min for 10 min and aliquoted in 1 ml 127 
tubes. CK and U were measured immediately in singlicate assays, using a Unicel DxC600 128 
synchron clinical system (Beckmann Coulter GmbH, Krefeld, Germany). The remaining 129 
aliquots were frozen within 1 h from sampling and stored frozen at -80°C until analysis. After 130 
completion of the respective training phase, FT (measured in duplicate, whereby the mean of 131 
the two values were used for analysis) and C (singularly) were measured using a commercial 132 
ELISA an Access 2 Immunoassay System (Beckman Coulter, California, USA) measured kit 133 
(Labor Diagnostika Nord, Nordhorn, Germany). Blood concentrations are expressed in 134 
‘commonly used’ clinical units (CK, U/L; U, mg/dl; C, µg/dl; FT, ng/ml). For standardised 135 
units listed as follows are the conversion factors:  136 
U- mg/dl to nmol/l = x0.357 137 
C - µg/dl to nmol/l = x27.59 138 
FT – ng/ml to nmol/l = x3.50 139 
 140 
Prior to blood collection, each participant completed the Acute Recovery and Stress Scale 141 
(ARSS) (12) to confirm that indeed the weeks of training did cause a sensation of perceived 142 
fatigue.  143 
 144 
Statistical analysis 145 
Statistical analysis was conducted using SPSS v21.0 (SPSS inc., Chicago, USA). Normal 146 
distribution was checked using the Shapiro Wilks tests. Although for some outcome measures 147 
this test was slightly above the significance level for certain time points, the distributions 148 
from the respective histograms were not skewed. Therefore, parametric procedures were 149 
applied throughout. Descriptive statistics are presented as means and standard deviations 150 
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(SD). A mixed linear model was fit to the data for inferential testing and estimation of 151 
between and within-subject variability, respectively (random effect: subject ID; fixed effects: 152 
fatigue status (Monday vs. Friday) and training period (LIHV vs. HILV)). Mean coefficients 153 
of variation (CV) were calculated to analyse the between-week reproducibility of measured 154 
values (separately for fatigued and recovered states, respectively) and their fatigue induced 155 
changes. All CV analyses were conducted using a macro from a published Microsoft Excel 156 
Spreadsheet (10). CVs were calculated separately for LIHV and HILV respectively. Students 157 
paired T-tests were used to compare Monday and Friday questionnaire results for both LIHV 158 
and HILV, significance was set at an alpha (P) level ≤0.05. 159 
 160 
The proceedings for the analysis of response patterns are illustrated in Figure 3. This novel 161 
approach was designed to allow for the transparent and reproducible operationalisation of the 162 
initial research question. Firstly Monday-to-Friday differences (Friday (fatigued) minus 163 
Monday (recovered)) were calculated for each individual parameter (∆CK and ∆U, ∆FT and 164 
∆C, respectively). The respective ratios (∆CK/∆U; ∆FT/∆T) based on changes in the 165 
individual parameters categorised by their magnitude were then created. The upper / lower 166 
limits for the extreme categories were set at mean difference ± 2 SD. To characterise the 167 
pairwise response pattern, the ratios of categorised changes in CK and U, as well as for FT 168 
and C, were calculated. Overall, group-based reproducibility of ratio values (∆CK/∆U, 169 
∆FT/∆C) was assessed using CV as described above. Individual cases were then evaluated by 170 
whether the ratio consistently fell into the same range during all weeks of a training phase. 171 
The authors deemed any value ≥1.1 indicated a CK or FT response and a value of ≤0.9 172 
indicates a U or C response from their respective pairs.  173 
 174 
Figure 3 about here 175 
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 176 
For a qualitative evaluation of response patterns involving all four parameters (subjectively 177 
observed pattern shape and change in shape), categorised changes were illustrated using 178 
spider diagrams with a diamond representing each week, the shape of this diamond can be 179 
used for week-by-week comparison of response and further inform the practitioner of 180 
‘responder’ type and alterations in athlete response. A single spider diagram was used for 181 
each of the training phases.  182 
 183 
During analysis it became apparent that several Monday values of CK were considerably 184 
higher compared to the preceding Friday. Therefore, when Monday values were elevated by 185 
more than the estimated week-by-week random variability (CV) compared to the preceding 186 
Friday, the week was excluded from the analysis. In total nine CK values were excluded.  187 
 188 
RESULTS: 189 
The results of the ARSS indicated that during the LIHV phase each of the eight dimensions 190 
were significantly different between Monday (rested) and Friday (fatigued) P = <0.05. 191 
During the HILV phase dimensions one to six and eight were significantly different between 192 
Monday (rested) and Friday (fatigued) P = <0.05, moreover, there was a trend of significance 193 
for dimension seven P = 0.06 194 
 195 
The characteristics of the subjects included in the analysis were; age 18 ± 3 y, height 177 ± 7 196 
cm, mass 67 ± 9 kg.  No significant differences were found between swimmers and triathletes 197 
for age, height, mass, years trained, any of the four blood-borne outcome measures or their 198 
changes (P = <0.05 in all cases) or relative number of existent patterns. For sexes, although 199 
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the number of participants does not yield statistical power, qualitatively, they were observed 200 
to response in a similar manner.  201 
 202 
CK, U, FT and C Monday and Friday measured values and the respective fatigue-induced 203 
differences within each training phase are presented in Table 1. According to the fixed effects 204 
results from the linear mixed model the difference between all Monday and Friday values 205 
independent of training phase (fixed effect: fatigue status) was significant for CK and U (P = 206 
<0.01 & P = 0.01 respectively), whereas for FT and C the numerical difference failed to 207 
reach statistical significance (P = 0.46 & P = 0.74 respectively). The effect of training phase 208 
on the week-by-week changes (LIHV vs. HILV) were significant for U (P = <0.01) but not 209 
for CK (P = 0.31), C (P = 0.92) and FT (P = 0.09).  210 
  211 
 Table 1 about here 212 
 213 
Usual group-based measures of reproducibility indicate a moderate-to-low reproducibility in 214 
the measured values for Mondays and Fridays in all outcome measures (CV 12-51%). Very 215 
poor reproducibility was seen for the fatigued-induced changes in all outcome measures with 216 
a mean CV ≥100 % in all cases (Table 2). Exemplary figures of the individual courses 217 
indicating the fatigue-induced changes in the associated blood-borne indicators are displayed 218 
in Figure 4. The respective graphs for Monday and Friday measured values for all parameters 219 
are provided as supplementary material (http://links.lww.com/JSCR/A14). According to the 220 
random effects results from the linear mixed model the proportion of between-subject 221 
variability from total variability is 45% for CK, 57% for U, 51% for FT and 57% in C.  222 
 223 
Table 2 about here 224 
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 225 
Figure 4 about here 226 
 227 
Ratios of categorised responses (bivariate response patterns) are displayed in Table 3. 228 
Athletes with a consistent pattern within a training phase are highlighted in degrees of grey. 229 
Case-wise analysis indicated consistent ∆CK/∆U patterns for seven individuals in LIHV and 230 
seven in HILV; five responded consistently throughout. For ∆FT/∆C the number of 231 
consistent patterns was two in the LIHV and three in the HILV phase. Selected exemplary 232 
spider diagrams conveying patterns including all four parameters, using their categorised 233 
values are displayed in figures 5a, 5b, 5c and 5d. These indicate a visual interpretation over 234 
an array of blood-borne parameters. 235 
 236 
Table 3 about here 237 
 238 
Figure 5 about here 239 
 240 
DISCUSSION: 241 
In competitive and elite sports there is a high awareness of the athletes’ individuality (9). 242 
Despite this awareness, formalised, objective standards (like normal ranges for individual 243 
fatigue markers) are still mostly based on group means and main effects leaving the 244 
individualisation to the experience and subjective valuation of the coach. This proof-of-245 
concept trial was designed to offer a simple, cost efficient and understandable approach to 246 
assess and handle the athletes’ individuality in a more objective way.  Moreover, the current 247 
study aimed to address the premise that the pattern of response remains consistent in various 248 
athletes during training micro cycles. The commonly used, group-based measurements of 249 
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reproducibility, demonstrated a high degree of random variability in fatigue-induced 250 
responses. This was seen in all parameters examined and within the response patterns. 251 
However, when data were analysed on the individual level, consistent relationships between 252 
the magnitudes of fatigue-induced changes in the selected parameters were apparent in a 253 
proportion of athletes. This finding supported the study aims and seminal practical 254 
observation that individualised patterns of fatigue indicators is present in certain athletes.  255 
 256 
The comparison between the two differing training phases (LIHV and HILV, respectively) 257 
extends this main finding by contributing multiple aspects. On the one hand side it 258 
corroborates the description of consistent, individual patterns, as seen in the current study, as 259 
a variety of athletes elicited the same blood-borne response, despite differences in training 260 
characteristics between the two phases. On the other hand side, this points to the need of 261 
taking current training characteristics into account when interpreting fatigue indicators, in 262 
particular when the consistency of response patterns between training phases has not been 263 
confirmed before for the concerned individual.  264 
 265 
At present, the high variability of surrogate markers for fatigue and recovery leads to wide 266 
reference ranges and thereby severely limits their diagnostic value (19). The individual 267 
patterns of fatigue-associated responses, apparent in our data, may partly explain this 268 
variability. This is supported by the important contribution of inter-individual variation to 269 
overall variability in measured values and responses. Beyond the multivariate approach 270 
associated with the assessment of response patterns, this insight may translate to individualise 271 
ranges of normality for individual markers and thereby to an improvement in their diagnostic 272 
accuracy for the assessment of fatigue. Such personalised normal ranges, which, for other 273 
parameters, are already successfully implemented in the athlete’s biological passport (ABP) 274 
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(20). The concept of the ABP is a means of monitoring an individual’s long-term 275 
haematological or steroid profile, whereby, when large discrepancies are discovered between 276 
the history of an athlete’s values and values obtained in a recent test implies that there is 277 
something that has altered the physiological condition of the athlete, be it from an act of 278 
doping or a medical condition which would warrant further investigation (20). This concept 279 
exemplifies the paradigm of personalised medicine while avoiding additional cost and effort. 280 
However, the practical applicability of this approach for the assessment of fatigue and 281 
recovery in competitive sports remains to be demonstrated, i.e. by establishing a better long-282 
term outcome compared to another approach. 283 
 284 
Previous research that investigates blood-borne indicators of fatigue is predominately based 285 
on a two-dimensional concept of fatigue. In other words, changes in fatigue status were 286 
mainly quantified as “more” or “less” fatigue with little attention to qualitative differences in 287 
fatigue states (25). However, mere quantification may not be sufficient to fully characterise 288 
the fatigue status of athletes who may not only be “more” or “less” but also “differently” 289 
fatigued. An explanatory example is the relationship between the muscular aspect of fatigue, 290 
reflected by an increase in CK (as a result from accumulated membrane damage; as 291 
compared to metabolic fatigue reflected e.g. by an increase in urea (as a result of limited 292 
carbohydrate availability and protein turnover) (17).  The ∆CK/∆U ratio makes this 293 
qualitative aspect of fatigue measurable. By contrast the components of the ∆FT/∆C ratio 294 
reflect the same aspect of fatigue (anabolic-catabolic balance) and the ratio is established in 295 
order to increase contrast and facilitate detection. However, it remains to be seen whether and 296 
to which extent the analysis of these ratios can be established across varying other training 297 
stimuli and sports.  298 
 299 
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As previously stated, the two-dimensional approach to fatigue could prove to be insufficient 300 
in the overall quality of an athletes fatigue level. Furthermore, the use of few parameters to 301 
monitor this fatigue could also prove to be insensitive in said fatigue determination. The plots 302 
(Figure 5) were created to visualise ‘responder type’, for several dimensions. This tool can 303 
potentially serve as independently as its own fatigue marker (Figure 5a & 5b), this could act, 304 
whereby if the shape dramatically changes can indicate an extreme or different stressor 305 
placed upon the athlete. Furthermore, this concept could lead to a progression in the future 306 
when the similarities between the multivariate responses are valuated objectively by 307 
bioinformatics approaches (e.g. neural networks). 308 
 309 
Exercise mode or the characteristics of certain disciplines are well known factors which can 310 
influence changes in fatigue indicators that occur during normal training cycles (5, 8). 311 
Prominent examples of relevant discipline characteristics affecting fatigue indicators are 312 
eccentric force production and calorie turnover (4). Training status and adaptation to the 313 
specific training load are important subject-inherent factors. To exclude such obvious sources 314 
of variability, a homogeneous sample of junior elite athletes from two related disciplines was 315 
included. As such, our results did not reveal any difference between disciplines in the 316 
measured values of the blood-borne markers, in the extent of the fatigue-induced changes or 317 
in the number of response patterns. 318 
 319 
It is beyond the scope of this study to uncover the causes for the observed inter-individual 320 
differences in patters of fatigue markers. However, it seems plausible that determinants 321 
include subject-inherent factors such as muscle fibre distribution. Totsuka et al., (23) 322 
previously showed that those athletes with a lower cross-sectional area of the quadriceps 323 
femoris muscle were “high responders” in CK production. Other inter-individual differences 324 
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could include consistent lifestyle characteristics e.g. nutritional habits. An example may be 325 
caloric restriction or protein supplementation, which would both favour increases in urea 326 
concentration (14). Research in the individualisation of an athlete’s response is clearly 327 
warranted to further our current understanding of the fatigue and recovery spectrum in 328 
regards to the specific nature not only of certain disciplines but also of each individual athlete 329 
(9).  330 
 331 
Given the novelty of the approach, this study bears some of the limitations typical for a field-332 
based proof-of-concept trial. Due to the observational character of the study, the 333 
opportunities for standardisation and control were limited to the training and blood sampling. 334 
The behaviour of subjects outside the normal training routines could not be controlled, 335 
comparable to circumstances during routine training periods. The lack of standardisation 336 
outside the training bouts became apparent with some CK values on Mondays being clearly 337 
higher in comparison to the preceding Friday. This is most probably due to unaccustomed 338 
spare time activities during the weekend. To alleviate this issue and avoid skewed results, 339 
Monday CK values were excluded from analysis when the value compared to the preceding 340 
Friday was higher than the expected random variability indicated by the CV (nine cases). 341 
While this added to the complicacy of the analyses and led to a loss in analysable data, non-342 
standardised spare time activity is commonplace even in elite sports. Therefore, this study 343 
design contributes to the external validity of the obtained results.  344 
 345 
In sport science the “gold standard” for evaluating fatigue is testing the maximal, discipline 346 
specific ability of an athlete and noting differences in occasion (26). Less physically 347 
demanding exercise based measures such as exercise heart rate at submaximal workloads or 348 
jump height have also been published (13, 22). However, as any exercise tests interferes with 349 
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the training routine this was not acceptable for the recruited elite athletes and their coaches. 350 
Therefore, the main effects of established blood-borne fatigue markers, validated 351 
questionnaires and the training load from daily training logs were used to ascertain changes 352 
in fatigue status. These included an individualised observation of each athletes training 353 
schedule, the overall significant differences in CK and U and the significant differences in the 354 
vast majority of the questionnaire results.   355 
 356 
While the athletes were informed to keep their meals as similar as possible throughout the 357 
days prior to and of the morning of blood collection, no food diaries were kept. This may 358 
potentially contribute to within-subject variation, in particular for urea. In addition, outcome 359 
measures for this study were limited to four classical fatigue indicators. In future research, a 360 
higher number of indicators should be included the selection of which may be either 361 
hypothesis-driven or exploratory.  362 
 363 
Aiming at a balanced and applicable definition of what is a “consistent response” (and in the 364 
absence of previous published work) a narrow and symmetrical “neutral zone” for the 365 
respective ratio was combined with a strict notion of “consistent” (above (≥1.1) or below 366 
(≤0.9) neutral for all weeks studied) this had been fixed a priory by the research team. The 367 
aim was to ensure contrast between response types while avoiding to be overly restrictive in 368 
the classification of individual weeks. A systematic evaluation of different cut-off values may 369 
be warranted in the future but requires follow-up studies with a higher number of subjects. 370 
Assessing consistency of larger patterns by visual inspection of the respective spider 371 
diagrams bears a preliminary character due to subjective component. However, in some cases 372 
there was an undisputable similarity of patters within a training phase. In larger follow-up 373 
trials, quantification of this similarity may be attempted using e.g. neural networks. 374 
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 375 
PRACTICAL APPLICATION: 376 
The use of longitudinal observations of several micro cycles in the present study confirmed 377 
that: considerable contribution of inter-individual differences to the large overall variation in 378 
blood born markers of fatigue, their changes with training and recovery as well as in the 379 
relative magnitude of changes in different parameters (patterns). Therefore: 380 
 381 
•  Individualised interpretation of observed values will probably help to overcome the 382 
longstanding problem of large variability in surrogate markers of fatigue in all 383 
different forms of athletes.  384 
At present coaches and team physicians should be encouraged to consider previous 385 
observations in the individual athlete in addition to fixed reference ranges. Future 386 
research is warranted to develop objective algorithms for the individualization of 387 
normal ranges in fatigue assessment. Starting points may be the statistical approaches 388 
used in the athlete biological passport (20) or in the field of “personalized medicine” 389 
(7).   390 
•  Patterns of changes in fatigue indicators may provide additional information as 391 
compared to individual parameters, at least in athletes with consistent responses. 392 
However, the possible increase in diagnostic accuracy remains to be determined in 393 
experimental follow-up trials.  394 
 395 
CONCLUSION: 396 
The present observational study is the first to systematically distinguish consistent individual 397 
patterns of response in blood-borne parameters of fatigue in a proportion of athletes. 398 
Together with the considerable between-subject variability in individual markers and their 399 
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changes, this clearly points to the potential value of individualised diagnostic approaches as 400 
compared to group-based ‘normal ranges’ of individual markers when optimal accuracy is 401 
intended, as it is usually the case in high-performance competitive sports. 402 
 403 
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FIGURE CAPTIONS: 475 
Figure 1: Details of the participants’ timeline throughout the study. 476 
Figure 2: Details of mean training loads for swimmers and triathletes during both low 477 
intensity high volume (LIHV) and high intensity low volume (HILV) training phases.  478 
Figure 3: Schematic representation of data preparation for analysis of response patterns.  479 
 CK: Creatine Kinase; U: urea; FT: Free-Testosterone; C Cortisol; ∆: Monday to 480 
 Friday  changes. 481 
Figure 4:  482 
 Individual courses of mean fatigue-associated differences (∆) of response in the 483 
 measured blood-borne parameters. Each line pertains to a single subject, whereby; 484 
 line type and marker symbol remains constant per individual. 485 
 CK: Creatine Kinase; U: urea; FT: Free-Testosterone; C Cortisol; LIHV: low intensity 486 
 high volume; HILV high intensity low volume.  487 
Figure 5: Selected spider diagrams of categorised responses in blood-borne markers: 488 
 a and b: Examples of consistent response pattern. 489 
 c and d Examples without consistent response pattern. 490 
Supplementary Figure 1: Individual courses of the mean fatigue-associated response in 491 
 blood-borne parameters, Mondays (Mon) and Fridays (Fri). Each line pertains to a 492 
 single  subject, whereby; line type and marker symbol remains constant per 493 
 individual. 494 
 CK: Creatine Kinase; U: urea; FT: Free-Testosterone; C Cortisol; LIHV: low 495 
 intensity high volume; HILV high intensity low volume.  496 
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Table 1: Mean ± standard deviation of raw values and mean differences of Monday and Friday values over both training phases. 
 LIHV HILV 
Time point Week 1 Week 2 Week 3 Week 4 Week 5 Mean Week 1 Week 2 Week 3 Week 4 Mean 
CK (U/L) 
 
Mon 
 
 
190.7±74.7 
 
 
187.3±90.5 
 
 
209.1±95.1 
 
 
178.2±57.2 
 
 
173.2±52.0 
 
 
191.3±70.5 
 
 
224.7±83.9 
 
 
207.5±92.0 
 
 
194.9±82.8 
 
 
194.6±101.1 
 
 
208.4±77.1 
 
 Fri 
 
262.1±150.3 
 
286.3±126.9 
 
256.4±141.3 
 
280.5±133.5 
 
271.9±164.4 
 
271.4±119.4 
 
275.4±144.8 
 
264.7±137.5 
 
261.1±105.5 
 
240.8±117.7 
 
263.7±110.2 
 
∆  
 
71.5±98.9* 
 
99.0±99.2* 
 
47.9±104.9* 
 
110.6±115.5* 
 
115.2 ±158.1* 
 
76.3±73.9* 
 
35.5±69.8* 
 
19.2±37.8* 
 
66.3±37.8* 
 
22.5±65.1* 
 
35.9±54.1* 
U (mg/dl) 
 
Mon 
 
 
32.9±8.4 
 
 
31.1±5.3 
 
 
33.4±8.5 
 
 
31.2±4.6 
 
 
28.8±7.0 
 
 
32.2±7.0 
 
 
35.1±7.5 
 
 
36.6±7.4 
 
 
37.6±7.4 
 
 
32.3±5.7 
 
 
35.4±7.1 
 
Fri 
 
36.1±5.3 
 
34.4±7.6 
 
33.6±8.8 
 
35.5±10.4 
 
33.5±6.8 
 
34.9±8.3 
 
37.5±8.9 
 
36.7±6.0 
 
35.6±5.4 
 
35.6±5.7 
 
36.3±6.7 
 
∆  
 
2.7±5.0* 
 
3.1±4.3* 
 
-0.6±3.8 
 
9.2±7.5* 
 
4.1±8.1* 
 
3.8±5.1* 
 
2.4±3.1* 
 
0.1±2.9 
 
-2.1±2.8 
 
3.3±4.0* 
 
0.9±3.2 
FT (ng/ml) 
 
 Mon 
 
 
13.0±10.4 
 
 
13.7±11.2 
 
 
10.8±10.0 
 
 
11.5±9.6 
 
 
10.6±9.8 
 
 
12.2±10.3 
 
 
9.2±10.6 
 
 
9.6±13.3 
 
 
9.4±11.5 
 
 
10.3±16.8 
 
 
9.6±13.3 
 
Fri 
 
15.8±13.9 10.9±10.0 10.1±7.5 9.6±7.3 10.4±8.7 11.5±9.9 10.8±16.2 9.6±12.9 9.3±12.1 12.7±17.5 10.6±14.9 
∆ 1.6±2.6 -2.1±2.4 -1.6±2.8 -1.2±2.0 0.4±4.0 -0.9±2.5 1.5±3.2 0.0±0.4 -0.1±0.8 1.8±2.5 0.8±1.7 
C (µg/dl)  
 
Mon 
 
 
13.1±8.4 
 
 
12.6±6.3 
 
 
11.5±7.1 
 
 
13.1±8.5 
 
 
14.0±8.6 
 
 
12.6±7.6 
 
 
15.1±10.1 
 
 
11.1±7.4 
 
 
17.7±12.3 
 
 
9.7±3.4 
 
 
13.4±8.9 
 
Fri 
 
15.1±10.4 
 
10.8±7.8 
 
13.7±6.8 
 
11.4±7.3 
 
14.8±9.8 
 
12.7±8.1 
 
14.1±9.0 
 
11.4±4.8 
 
10.1±3.6 
 
12.6±7.1 
 
12.1±6.5 
 
∆  
 
3.1±4.0 
 
-1.0±2.3 
 
2.3±4.5 
 
-0.9±4.1 
 
4.2±10.3 
 
0.9±3.7 
 
-0.9±2.0 
 
0.3±3.2 
 
-7.5±5.9 
 
2.9±4.0 
 
-1.3±3.7 
Note: Creatine kinase (CK), Urea (U), Cortisol (C) and Free-testosterone (FT); Monday (Mon), Friday (Fri); Low intensity high volume training phase (LIHV), 
High intensity low volume training phase (HILV). 
*P = <0.05.  
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Table 2: Mean coefficients of variation (CV).  
Blood parameter  CK   U   C   FT  
 Time point Mon Fri ∆ Mon Fri ∆ Mon Fri ∆  Mon Fri  ∆ 
 
LIHV 
 
27.3 34.7 164.7 19.0 14.2 224.7 32.5 38.8 568.4 22.2 19.8 444.3 
 
HILV 
 
22.4 28.2 109.5 14.2 12.1 1334.6 50.6 37.1 152.9 22.5 26.3 383.3 
Note: CV expressed as %.  
Creatine kinase (CK), Urea (U), Cortisol (C) and Free-testosterone (FT). Mondays (Mon), Fridays (Fri) and differences (∆). Low intensity high 
volume training phase (LIHV), High intensity low volume training phase (HILV). 
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Table 3: Bivariate ratios of fatigue induced changes in outcome measures.  
 
∆CK/∆U Week 1 Week 2 Week 3 Week 4 Week 5 
 
Week 1 Week 2 Week 3 Week 4 
Subject 1 0.7 3.3 1.0 1.8 1.3 
 
1.0 0.8 8.0 1.0 
Subject 2 0.8 2.0 
 
1.4 1.3 
 1.2  1.7 1.2 
Subject 3 
 2.7 5.5 3.0 3.3  3.7 1.4 3.3 7.0 
Subject 4 0.5 
 
0.9 0.6 0.8  0.6 0.8 0.7 0.6 
Subject 5 0.6 8.0 2.3 1.7 1.1 
 
0.6 1.2 7.0 1.0 
Subject 6 
 
2.2 5.0 1.8 1.2  2.3 1.5 1.2 7.0 
Subject 7 0.5 0.8 0.4 
 
0.6  0.8 1.4 1.3 1.0 
Subject 8 2.8 0.5 2.8 1.1 
  2.7 4.3 3.3 11.0 
Subject 9 2.2 7.0 6.0  1.7  4.0 1.5 4.0 1.0 
Subject 10 10.0 2.3 7.0  13.0  2.0 1.7 1.7 7.0 
Subject 11 7.0 
 
2.0 2.0 2.0  1.7 8.0 3.5  
Subject 12 1.0 
 
1.2 0.5 0.5 
 
0.7 3.0 0.9 2.3 
∆FT/∆C Week 1 Week 2 Week 3 Week 4 Week 5 
 
Week 1 Week 2 Week 3 Week 4 
Subject 1 1.3 0.6 0.8 0.8 0.8 
 
0.6 0.5 5.0 0.5 
Subject 2 1.4 1.7 
 
1.5 1.2  0.5 0.5 4.0 1.5 
Subject 3 
 
0.6 0.9 1.3 1.0 
 
0.8 5.0 5.0 0.6 
Subject 4 0.7 1.7 0.9 1.7 4.0 
 
1.2 1.3 4.0 0.6 
Subject 5 0.7 1.0 9.0 2.0 0.2 
 
1.0 0.4 4.0 0.9 
Subject 6 
 
0.1 1.0 1.0 1.7 
 
3.0 1.7 5.0 0.9 
Subject 7 0.3 1.3 2.0 
 
1.8 
 
0.9 0.5 1.6 1.0 
Subject 8 4.0 1.0 1.0 0.3 
  0.4 0.3 0.3 0.1 
Subject 9 0.8 3.5 0.3 
 
1.0 
 1.5 1.5 2.0 2.5 
Subject 10 2.0 0.7 0.1 1.0 1.2 
 
0.4 1.0 0.6 1.8 
Subject 11 1.0 
 
0.4 0.4 0.4 
 
1.1 0.7 0.8 0.8 
Subject 12 1.2 
 
1.2 1.3 1.3  0.6 0.5 0.4 0.4 
Note: Categorized Monday – Friday differences (∆) for creatine kinase divided by urea (∆CK/∆U) and free-testosterone divided by cortisol (∆FT/∆C). Values 
of 1.1 or greater indicate a CK or FT response respectively, which are highlighted in darker grey; values of 0.9 or less indicate a U or C response respectively, 
which are highlighted in lighter grey. 
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